Brief: JHBP CY Says NMPA Accepts New Drug Application For GB242
03/11/2020 15:03
Nov 3 (Reuters) - JHBP CY Holdings Ltd 6998.HK :
* NMPA ACCEPTS NEW DRUG APPLICATION FOR GB242
Source text for Eikon: ID:nHKSbRccWQ
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman